News | Conferences
6th Annual Meeting of Oral Oncology 2017
6th Day of Oral Oncology, October 22, 2017 Athens Organized … Read more
1st Meeting of the Members of HeSHNCA
News 1st Meeting of the Members of HeSHNCA. The 1st … Read more
European Organization for Research and Treatment of Cancer-EORTC Head & Neck Cancer Group Meeting, Friday 18 and Saturday 19 March, 2016.
The Spring Meeting of the Head and Neck Group took … Read more
Message from Dr. Amanda Psyrri, Kestrel International Coordinating Investigator
Dear Investigators,
As the international co-PI of Kestrel, I would like to share with you my great enthusiasm for this randomized phase III study evaluating concurrent tremelimumab and durvalumab vs durvalumab monotherapy vs standard of care (EXTREME) as first line treatment in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.